FLT3 and neoplasm: In situ vaccination combining Fms-like tyrosine kinase 3 (Flt3), poly-ICLC, and radiotherapy induced antitumor CD8 + T cell responses in patients with advanced stage indolent NHL, some of whom had a heavy tumor burden [79].